Charlotte Charpentier

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

Véronique Joly, Charles Burdet, Roland Landman et al. · Journal of Antimicrobial Chemotherapy · 2018 · 80 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses

V. Gounant, Valentine Marie Ferré, Ghassen Soussi et al. · Journal of Thoracic Oncology · 2021 · 62 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

Lise Cuzin, Pascal Puglièse, Christine Katlama et al. · Journal of Antimicrobial Chemotherapy · 2018 · 49 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure

Signe Fransen, Marina Karmochkine, Wei Huang et al. · Antimicrobial Agents and Chemotherapy · 2009 · 47 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study

Charlotte Charpentier, Brigitte Montès, Marine Perrier et al. · Journal of Antimicrobial Chemotherapy · 2017 · 44 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17